Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?

被引：12
|
作者：
Rezzola, Sara [1 ]
Nawaz, Mohd I. [1 ]
Cancarini, Anna [2 ]
Semeraro, Francesco [2 ]
Presta, Marco [1 ]
机构：
[1] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy
[2] Univ Brescia, Dept Neurol & Vis Sci, Eye Clin, Brescia, Italy
来源：
DIABETES CARE | 2019年 / 42卷 / 07期
关键词：
D O I：
10.2337/dc18-2527
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E105 / E106
页数：2
相关论文
共 50 条
  • [41] Elevated LRP6 levels correlate with vascular endothelial growth factor in the vitreous of proliferative diabetic retinopathy
    Gao, Xinxiao
    Ma, Kai
    Lu, Ning
    Xu, Yongsheng
    Hong, Tingting
    Peng, Xiaoyan
    MOLECULAR VISION, 2015, 21 : 665 - 672
  • [42] Vitreous, aqueous, and serum levels of vascular endothelial growth factor and angiopoietin-2 in patients with proliferative diabetic retinopathy and diabetic macular edema
    Rasol, Hoiyda A. Abdel
    MIDDLE EAST AFRICAN JOURNAL OF OPHTHALMOLOGY, 2007, 14 (01) : 3 - 6
  • [43] Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy -: A case-control study
    Hernández, C
    Burgos, R
    Cantón, A
    García-Arumí, J
    Segura, RM
    Simó, R
    DIABETES CARE, 2001, 24 (03) : 516 - 521
  • [44] Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II
    Funatsu, H
    Yamashita, H
    Noma, H
    Mimura, T
    Sakata, K
    Hori, S
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (08) : 1064 - 1068
  • [45] Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy
    Mitamura, Y
    Suzuki, T
    Miyano, N
    Tashimo, A
    Ohtsuka, K
    Mizue, Y
    Nishihira, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U949 - U949
  • [46] Placenta growth factor and vascular endothelial growth factor in the vitreous of patients with proliferative vitreoretinopathy
    Mitamura, Y
    Tashimo, A
    Ohtsuka, K
    Mizue, Y
    Nishihira, J
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2005, 33 (02): : 226 - 227
  • [47] Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
    van Buggenum, IMH
    Polak, BCP
    Reichert-Thoen, JWM
    de Vries-Knoppert, WAEJ
    van Hinsbergh, VWM
    Tangelder, GJ
    DIABETOLOGIA, 2002, 45 (02) : 203 - 209
  • [48] Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy
    I. M. Hogeboom van Buggenum
    B. C. P. Polak
    J. W. M. Reichert-Thoen
    W. A. E. J. de Vries-Knoppert
    V. W. M. van Hinsbergh
    G. J. Tangelder
    Diabetologia, 2002, 45 : 203 - 209
  • [49] Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
    Chung, Eun Jee
    Kang, Shin Jeong
    Koo, Ja Seung
    Choi, Yoon Jung
    Grossniklaus, Hans E.
    Koh, Hyoung Jun
    YONSEI MEDICAL JOURNAL, 2011, 52 (01) : 151 - 157
  • [50] ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy
    Lu, Qianyi
    Zou, Wenjun
    Chen, Bin
    Zou, Chen
    Zhao, Minjie
    Zheng, Zhi
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (07) : 1281 - 1288
12345